Immunohistochemical assays revealed that tumors treated with EYFs for 6 and 12 h drastically reduced the density of CD31+ microvessels and the number of Ki67+ proliferative tumor cells as well as cleaved Caspase‐3+ apoptotic tumor cells (Figure 4E). The gene discussed is MKI67; the disease is neoplasm.